Acer Therapeutics Inc. (ACER) Financial Statements (2024 and earlier)

Company Profile

Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.)
NEWTON, MA 02458
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,32912,7115,76212,07841,67115,644
Cash and cash equivalents2,32912,7115,76212,07841,67115,644
Inventory, net of allowances, customer advances and progress billings      
Inventory      
Prepaid expense7591,094   882
Deferred costs 408     
Other current assets209,284    
Other undisclosed current assets  5,0006798071,075 
Total current assets:3,51728,0896,44112,88542,74616,526
Noncurrent Assets
Property, plant and equipment21511413019413163
Intangible assets, net (including goodwill)7,6477,6477,6477,6477,6477,647
Goodwill7,6477,6477,6477,6477,6477,647
Other noncurrent assets2464073956212014
Other undisclosed noncurrent assets    119119119
Total noncurrent assets:8,1088,1688,1738,5817,9177,842
TOTAL ASSETS:11,62436,25714,61421,46650,66324,369
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7,4713,8345,4532,5065,5802,033
Accounts payable3,8131,4061,6725611,03496
Accrued liabilities3,6572,4283,7811,9444,5461,937
Debt      
Other liabilities7419,450692263  
Other undisclosed current liabilities10,74015,826    
Total current liabilities:18,95229,1106,1462,7695,5802,033
Noncurrent Liabilities
Long-term debt and lease obligation 6,048209    
Long-term debt, excluding current maturities 6,048     
Liabilities, other than long-term debt291209244326  
Other liabilities146209244326  
Operating lease, liability 146209  
Other undisclosed noncurrent liabilities 3,0958,452    
Total noncurrent liabilities:9,4348,871244326  
Total liabilities:28,38537,9816,3893,0955,5802,033
Equity
Equity, attributable to parent(16,761)(1,724)8,22418,37045,08322,336
Common stock2111175
Additional paid in capital123,984112,785107,35994,62091,91547,812
Accumulated deficit(140,747)(114,510)(99,136)(76,251)(46,833)(25,552)
Total equity:(16,761)(1,724)8,22418,37045,08322,336
TOTAL LIABILITIES AND EQUITY:11,62436,25714,61421,46650,66324,369

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues 1,260    
Cost of revenue
(Other undisclosed Cost of revenue)
      
Gross profit: 1,260    
Operating expenses(24,614)(17,208)(22,803)(29,897)(21,713)(13,948)
Other undisclosed operating loss      
Operating loss:(24,614)(15,948)(22,803)(29,897)(21,713)(13,948)
Nonoperating income (expense)(1,623)574(83)479432(246)
Investment income, nonoperating    471  
Gain (loss), foreign currency transaction, before tax(47)55(96)8  
Other nonoperating income (expense)     432(246)
Interest and debt expense 569    
Loss from continuing operations:(26,237)(14,805)(22,885)(29,418)(21,281)(14,194)
Loss before gain (loss) on sale of properties:(14,805)(22,885)(29,418)(21,281)(14,194)
Other undisclosed net income (loss) (569)    
Net loss:(26,237)(15,374)(22,885)(29,418)(21,281)(14,194)
Other undisclosed net income attributable to parent      
Net loss available to common stockholders, basic:(26,237)(15,374)(22,885)(29,418)(21,281)(14,194)
Other undisclosed net income available to common stockholders, diluted      
Net loss available to common stockholders, diluted:(26,237)(15,374)(22,885)(29,418)(21,281)(14,194)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(26,237)(15,374)(22,885)(29,418)(21,281)(14,194)
Comprehensive loss, net of tax, attributable to parent:(26,237)(15,374)(22,885)(29,418)(21,281)(14,194)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: